Novaccess Global Inc (XSNX)
0.015
+0.01
(+80.72%)
USD |
OTCM |
May 17, 16:00
Novaccess Global Net Income (Quarterly): 1.304M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.304M |
| September 30, 2023 | -1.768M |
| June 30, 2023 | -0.7796M |
| March 31, 2023 | 0.4538M |
| December 31, 2022 | -2.631M |
| September 30, 2022 | -0.0578M |
| June 30, 2022 | -0.4666M |
| March 31, 2022 | -1.230M |
| December 31, 2021 | -0.1433M |
| September 30, 2021 | 0.0989M |
| June 30, 2021 | -2.097M |
| March 31, 2021 | -0.6692M |
| December 31, 2020 | 0.1551M |
| September 30, 2020 | -7.415M |
| June 30, 2020 | 0.7081M |
| March 31, 2020 | 0.0385M |
| December 31, 2019 | -0.1017M |
| September 30, 2019 | 0.916M |
| June 30, 2019 | -0.4604M |
| March 31, 2019 | 0.4824M |
| December 31, 2018 | 1.406M |
| September 30, 2018 | 2.828M |
| June 30, 2018 | -6.272M |
| March 31, 2018 | -0.4592M |
| December 31, 2017 | -0.0665M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.3363M |
| June 30, 2017 | -0.1598M |
| March 31, 2017 | 0.033M |
| December 31, 2016 | -0.0355M |
| September 30, 2016 | -0.1315M |
| June 30, 2016 | -0.2404M |
| March 31, 2016 | 0.1605M |
| December 31, 2015 | -0.0314M |
| September 30, 2015 | -0.4227M |
| June 30, 2015 | -0.0641M |
| March 31, 2015 | -0.8569M |
| December 31, 2014 | 0.0231M |
| September 30, 2014 | -0.3939M |
| June 30, 2014 | -0.1238M |
| March 31, 2014 | -0.3755M |
| December 31, 2013 | -1.057M |
| September 30, 2013 | -0.6968M |
| June 30, 2013 | -0.297M |
| March 31, 2013 | -0.9939M |
| December 31, 2012 | -0.5346M |
| September 30, 2012 | -0.2001M |
| June 30, 2012 | -0.6179M |
| March 31, 2012 | -0.2887M |
| December 31, 2011 | -0.4485M |
| September 30, 2011 | -0.3051M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-7.415M
Minimum
Sep 2020
1.304M
Maximum
Dec 2023
-0.7445M
Average
-0.1433M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| CEL-SCI Corp | -7.245M |
| AIM ImmunoTech Inc | -12.58M |
| IGC Pharma Inc | -5.589M |
| NovaBay Pharmaceuticals Inc | -3.214M |
| Protalix BioTherapeutics Inc | -4.595M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.2575M |
| EPS Diluted (Quarterly) | 0.01 |
| Enterprise Value | 2.601M |
| Earnings Yield | -666.7% |
| Operating Earnings Yield | 8.88% |
| Normalized Earnings Yield | 38053.43 |